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More than 20% of the UK population live in rural areas (Cox,
1995) but there is little information on rural–urban patterns of
cancer survival (Watt et al, 1993). Studies in other countries
suggest that rural residence is associated with poorer survival,
which could reflect more advanced stage at diagnosis and less
adjuvant treatment (Bonett et al, 1990; Liff et al, 1991; Launoy
et al, 1992). In the UK, the few studies of rural health in general
have produced conflicting results but, overall, challenge the wide-
spread belief that rural people have a health advantage over their
urban counterparts (Phillimore and Reading, 1992; Watt et al,
1993; Cox, 1998).
This study set out to investigate whether survival from cancer
differed for patients resident in rural and urban areas. Two main
rural indicators are associated with health: size of the local popula-
tion and distance from health services (Weinert and Boik, 1995).
In this paper, the hypotheses to be tested were that: (1) settlement
size and (2) distance to the nearest cancer centre were associated
with poorer survival.
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Table 1 Characteristics of cases included in analysis
Lung Colorectal Breast Stomach Prostate Ovary
First analysis
Cases with a first primary 21 318 14 263 14 265 4765 6833 2532
tumour
No. (%) male 13 344 (63) 7087 (50) 0 (0) 2833 (59) 6833 (100) 0 (0)
Mean (s.d.) age 69 (10) 70 (12) 62 (15) 71 (11) 74 (9) 64 (14)
No. (%) who died on date of 1862 (9) 614 (4) 445 (3) 300 (6) 275 (4) 83 (3)
diagnosis
No. (%) male 1127 (61) 241 (39) 0 (0) 142 (47) 275 (100) 0 (0)
Mean (s.d.) age 74 (10) 78 (10) 82 (11) 76 (10) 80 (8) 75 (12)
Second analysis
Cases (first tumour) followed 19 449 13 645 13 817 4464 6555 2449
up for at least 1 daya
No. (%) male 12 214 (63) 6844 (50) 0 (0) 2690 (60) 6555 (100) 0 (0)
Mean (s.d.) age 69 (10) 70 (11) 61 (14) 70 (11) 73 (9) 64 (14)
No. (%) who died on or 16 433 (84) 6495 (48) 2940 (21) 3479 (78) 2644 (40) 1406 (57)
before 31 December 1995
No. (%) male 10 343 (63) 3252 (50) 0 (0) 2093 (60) 2644 (100) 0 (0)
Mean (s.d.) age 69 (10) 72 (12) 68 (15) 71 (11) 76 (9) 68 (12)
aExcludes 3579 cases who died on the first day and 18 other cases who were followed up for less than 1 day.METHODS
Data on lung, colorectal, breast, prostate, stomach and ovarian
cancers diagnosed between 1 January 1991 and 31 December 1995
were obtained from the Scottish cancer registry. Based on post-
code of residence at diagnosis, 70 561 of 71 152 registrations were
successfully matched to census output areas, which were used to
assign geographical and socio-economic variables (output areas
are the smallest census units in Scotland – median population 124,
interquartile range 98–156). Cases registered with a first primary
tumour (63 976) were eligible for analysis (Table 1).
Survival was calculated from date of diagnosis to date of death
or 31 December 1995, whichever was sooner (median follow up
0.68 years; range 0–5 years). Distance quintiles were assigned
based on the shortest straight-line distance to the nearest cancer
centre. The quintiles represented ≤ 5 km, 6–13 km, 14–23 km,
24–37 km and ³ 38 km. Census indicators of settlement size were
used, representing populations of > 1 000 000, 100 000–1 000 000,
10 000–100 000, 1000–10 000 and < 1000. Deprivation scores
were calculated using the method of Carstairs and Morris (1990)
but with output areas as the geographical units. Quintiles were
calculated with the least deprived coded ‘1’, and the most deprived
coded ‘5’ (Reading et al, 1993). Deprivation indices could not be
assigned for 33 cases due to missing census data.
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Table 2 Numbers and percentages of patients who were diagnosed on their date of death
Lung Colorectal Breast Stomach Prostate Ovary
n % n % n % n % n % n %
Carstairs deprivation quintile
1 – least deprived 190/2224 8.5 125/2635 4.7 102/3057 3.3 37/623 5.9 47/1384 3.4 16/500 3.2
2 290/3363 8.6 126/3049 4.1 103/3008 3.4 60/870 6.9 70/1558 4.5 15/529 2.8
3 389/4564 8.5 120/3047 3.9 87/3037 2.9 54/1059 5.1 60/1488 4.0 18/575 3.1
4 500/5710 8.8 135/3101 4.4 98/2953 3.3 71/1183 6.0 61/1433 4.3 17/535 3.2
5 – most deprived 492/5445 9.0 108/2427 4.4 55/2199 2.5 78/1026 7.6 37/968 3.8 17/393 4.3
P-valuea 0.388 0.777 0.124 0.312 0.662 0.371
Distance to cancer centre
≤ 5 km 435/5526 7.9 122/3313 3.7 74/3023 2.4 51/1135 4.5 55/1536 3.6 14/585 2.4
6–13 km 415/4520 9.2 107/2711 3.9 66/2696 2.4 64/987 6.5 51/1223 4.2 14/493 2.8
14–23 km 386/3764 10.3 126/2557 4.9 80/2738 2.9 65/875 7.4 54/1202 4.5 20/486 4.1
24–37 km 321/3786 8.5 119/2568 4.6 100/2854 3.5 52/855 6.1 47/1371 3.4 15/478 3.1
> 38 km 305/3722 8.2 140/3114 4.5 125/2954 4.2 68/913 7.4 68/1501 4.5 20/490 4.1
P-valuea 0.671 0.046 <0.001 0.016 0.429 0.127
Settlement size
> 1 000 000 670/7042 9.5 158/3567 4.4 119/3562 3.3 113/1390 8.1 56/1443 3.9 21/649 3.2
100 000–1 000 000 265/3563 7.4 100/2569 3.9 49/2393 2.0 36/847 4.3 53/1347 3.9 12/464 2.6
10 000–100 000 498/5783 8.6 169/3879 4.4 130/4048 3.2 76/1300 5.8 68/1860 3.7 22/738 3.0
1000–10 000 292/3332 8.8 116/2661 4.4 82/2687 3.1 42/827 5.1 59/1279 4.6 17/429 4.0
< 1000 137/1598 8.6 71/1587 4.5 65/1575 4.1 33/401 8.2 39/904 4.3 11/252 4.4
P-valuea 0.203 0.790 0.145 0.194 0.396 0.293
aChi-square test for linear trend.
Table 3 Odds ratios (OR) (95% confidence intervals (CI)) for death on date of diagnosis, adjusted for age, sex, distance to cancer centre and settlement size
Lung Colorectal Breast Stomach Prostate Ovary
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Distance to cancer centre
≤ 5 k m 1 –1 –1 –1 – 1 – 1 –
6–13 km 1.17 (1.01–1.36) 1.18 (0.89–1.56) 1.20 (0.83–1.73) 1.52 (1.03–2.26) 1.39 (0.92–2.10) 1.30 (0.58–2.93)
14–23 km 1.47 (1.22–1.77) 1.92 (1.35–2.71) 2.15 (1.41–3.30) 2.83 (1.77–4.53) 1.46 (0.85–2.51) 2.69 (1.01–7.14)
24–37 km 1.21 (0.97–1.52) 1.86 (1.25–2.76) 2.65 (1.62–4.34) 3.15 (1.78–5.57) 1.10 (0.60–2.02) 1.95 (0.63–6.01)
³ 38 km 1.14 (0.90–1.43) 1.78 (1.19–2.67) 2.87 (1.74–4.74) 3.92 (2.16–7.08) 1.36 (0.75–2.47) 2.47 (0.79–7.65)
P-value:
Global < 0.001 0.006 < 0.001 < 0.001 0.347 0.325
Linear trend 0.512 0.024 < 0.001 < 0.001 0.529 0.263
Settlement size
> 1 000 000 1 – 1 – 1 – 1 – 1 – 1 –
100 000–1000 000 0.78 (0.67–0.92) 0.90 (0.68–1.19) 0.54 (0.37–0.78) 0.64 (0.45–1.05) 1.14 (0.76–1.74) 1.02 (0.46–2.29)
10 000–100 000 0.81 (0.68–0.96) 0.66 (0.48–0.90) 0.51 (0.34–0.75) 0.36 (0.24–0.58) 0.94 (0.57–1.55) 0.63 (0.27–1.48)
1000–10 000 0.83 (0.68–1.01) 0.64 (0.45–0.90) 0.42 (0.27–0.64) 0.28 (0.18–0.50) 1.12 (0.67–1.87) 0.75 (0.30–1.86)
< 1000 0.84 (0.66–1.07) 0.72 (0.49–1.06) 0.54 (0.34–0.87) 0.45 (0.26–0.85) 1.01 (0.58–1.78) 0.90 (0.33–2.43)
P-value:
Global 0.009 0.088 < 0.001 < 0.001 0.867 0.812
Linear trend 0.016 0.066 0.001 < 0.001 0.670 0.952Data were managed using Microsoft Access version 2 and
analysed using SPSS for Windows release 7. Proportions of cases
whose date of diagnosis coincided with their date of death were
calculated. Logistic regression was used to model all variables
and calculate odds ratios relative to the first category within
each variable. Survival rates after diagnosis were calculated by
Kaplan–Meier analysis (Bland and Altman, 1998). Cox regression
was used to model all variables and calculate hazard ratios relative
to the first category within each variable (Cox, 1972).
RESULTS
In univariate analysis, a greater proportion of patients who lived
far from a cancer centre died on their date of diagnosis compared
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Table 4 One-year survivala of patients who survived at least 1 day from their date of diagnosis.
Lung Colorectal Breast Stomach Prostate Ovary
No. 1-year No. 1-year No. 1-year No. 1-year No. 1-year No. 1-year
starting survival starting survival starting survival starting survival starting survival starting survival
(%) (%) (%) (%) (%) (%)
Carstairs deprivation quintile
1 – least deprived 2033 24.0 2509 68.5 2955 92.5 586 28.9 1336 80.1 484 61.3
2 3072 23.5 2923 65.8 2904 91.0 810 30.6 1487 77.1 514 55.9
3 4175 21.2 2927 65.1 2949 88.3 1004 29.3 1427 76.3 557 56.1
4 5207 20.6 2964 62.5 2854 88.3 1112 26.2 1372 75.8 518 51.7
5 – most deprived 4951 21.2 2318 62.2 2144 86.1 948 28.9 931 71.9 376 50.8
P-valueb < 0.001 < 0.001 < 0.001 0.283 < 0.001 < 0.001
Distance to cancer centre
≤ 5 km 5090 21.7 3190 65.4 2949 87.8 1084 28.8 1480 74.9 571 58.3
6–13 km 4104 21.6 2603 63.6 2629 90.3 923 28.6 1172 76.3 479 55.4
14–23 km 3377 21.9 2431 65.0 2657 89.9 810 30.4 1148 76.8 466 52.2
24–37 km 3461 21.0 2448 65.1 2754 90.2 802 26.4 1323 78.5 463 55.7
³ 38 km 3417 22.1 2973 64.9 2828 89.0 845 29.1 1432 76.5 470 54.1
P-valueb 0.862 0.174 0.208 0.438 0.908 0.950
Settlement size
> 1 000 000 6370 20.2 3409 62.4 3442 87.6 1277 27.1 1387 70.4 628 51.7
100 000–1 000 000 3298 23.1 2467 65.6 2344 89.6 811 28.8 1293 78.4 452 61.8
10 000–1000 000 5280 21.7 3708 65.9 3917 89.9 1224 29.6 1791 79.3 716 53.3
1000–10 000 3040 22.0 2545 64.9 2604 90.2 785 30.2 1219 77.4 412 54.7
< 1000 1461 23.7 1516 66.1 1510 90.5 367 27.6 865 76.8 241 60.5
P-valueb < 0.001 < 0.001 0.001 0.021 < 0.001 0.071
aCalculated using the Kaplan–Meier method. bLog-rank test for trend.
Table 5 Proportional hazard ratios (95% confidence intervals) for survival after diagnosis, adjusted for age, sex, deprivation, distance to cancer centre and
settlement size
Lung Colorectal Breast Stomach Prostate Ovary
HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Distance to cancer centre
≤ 5 k m 1 – 1 – 1 –1 –1 –1 –
6–13 km 1.03 (0.98–1.08) 1.06 (0.98–1.15) 0.87 (0.77–0.98) 1.02 (0.92–1.13) 1.13 (1.00–1.28) 1.13 (0.95–1.34)
14–23 km 1.07 (1.01–1.14) 1.09 (0.99–1.21) 0.99 (0.86–1.15) 1.09 (0.95–1.26) 1.10 (0.94–1.30) 1.33 (1.06–1.65)
24–37 km 1.09 (1.02–1.18) 1.11 (0.99–1.25) 1.04 (0.88–1.22) 1.18 (1.01–1.38) 1.01 (0.84–1.21) 1.20 (0.94–1.54)
³ 38 km 1.09 (1.01–1.18) 1.11 (0.99–1.24) 1.07 (0.90–1.27) 1.13 (0.96–1.33) 1.23 (1.02–1.48) 1.15 (0.89–1.49)
P-value:
Global 0.160 0.355 0.057 0.322 0.009 0.118
Linear trend 0.024 0.108 0.301 0.122 0.042 0.562
Settlement size
> 1 000 000 1 – 1 – 1 – 1 – 1 – 1 –
100 000–1 000 000 0.94 (0.89–0.99) 0.92 (0.85–0.99) 0.84 (0.74–0.95) 0.94 (0.84–1.05) 0.74 (0.65–0.84) 0.87 (0.73–1.04)
10 000–100 000 0.93 (0.87–0.99) 0.87 (0.79–0.96) 0.81 (0.70–0.93) 0.83 (0.73–0.95) 0.73 (0.63–0.85) 0.89 (0.72–1.08)
1000–10 000 0.91 (0.85–0.98) 0.87 (0.78–0.97) 0.86 (0.74–1.00) 0.78 (0.68–0.90) 0.79 (0.67–0.93) 0.80 (0.64–1.00)
< 1000 0.86 (0.79–0.93) 0.90 (0.80–1.02) 0.86 (0.72–1.03) 0.92 (0.77–1.09) 0.80 (0.67–0.96) 0.82 (0.63–1.07)
P-value:
Global 0.002 0.023 0.005 0.005 < 0.001 0.235
Linear trend <0.001 0.052 0.044 0.027 0.014 0.039with those who lived nearby (Table 2). Trends were significant for
colorectal, breast and stomach cancers and persisted after
adjusting for age, sex and settlement size (Table 3). In the model-
ling exercise, small settlement size was an advantage for all sites
except prostate and these trends were significant for lung, breast
and stomach. The effect was, however, largely evident as a differ-
ence between the first category (patients living in a conurbation of
more than one million) and the rest.
For patients who survived at least 1 day after diagnosis,
increasing deprivation was associated with decreasing survival for
all sites except stomach (Table 4). Small settlement size was a
significant advantage for all sites except ovary. Adjusting for age,
sex, deprivation and distance, the survival advantage associated
with small settlement size was confirmed, although the effect was
again mostly seen between patients living in a conurbation of more
than one million and the rest. Increasing distance from a cancer
centre was significantly associated with poorer survival for lung
and prostate cancers.
DISCUSSION
Cancer registration data in Scotland have a high level of accuracy
compared to other registries. In comparison with medical records,
serious discrepancies were judged to have occurred in under 3% of
cases and postcode inaccuracies in 7% (Brewster et al, 1994). Our
findings could have been affected by bias if cancer registry data,
which are collected by case notes review, were less complete for
more remote patients. Several factors suggest that this is unlikely.
First, common methods of case ascertainment and registration are
used throughout Scotland, irrespective of where cases are resident.
Second, all records of deceased patients are collected together in
central stores so are equally accessible. Third, if our findings were
due to bias, they should have been consistent across all cancers,
which they were not. Finally, registration bias would not explain
the trend to poorer survival after diagnosis.
Standard area-based indicators of deprivation have been criti-
cised as insensitive in rural areas, where wealth and poverty can
coexist in close proximity. We minimized internal diversity by
using the smallest available area unit, an approach that has been
found effective at showing inequalities even in rural areas
(Reading et al, 1993).
Interpretation
We found no evidence that small settlement size was a survival
disadvantage. The only prominent association was poorer survival
for patients living in a conurbation of more than one million. In
Scotland, this is the extended Glasgow area and it seems likely
that local factors, perhaps including deprivation incompletely
controlled for by the Carstairs score, could have been responsible.
In the rest of Scotland, settlement size had little or no effect.
There was, however, strong evidence that increasing distance
from a cancer centre was associated with poorer survival. More
remote patients were less likely to be diagnosed before they died,
especially for stomach, breast and colorectal cancers. After diag-
nosis, there appeared to be a small disadvantage with increasing
distance, although this association was weaker.
Studies in other countries have found that patients with poor
access were more likely to present with disseminated disease for
breast, colorectal, prostate and lung cancers (Liff et al, 1991;
Launoy et al, 1992; Montella et al, 1995). They have also been
found less likely to be referred to specialist centres (Greenberg
et al, 1988a; Launoy et al, 1992) or receive adjuvant treatment
with radiotherapy and chemotherapy (Greenberg et al 1988b; Craft
et al, 1997). In Scotland, rural residence has been associated with
suboptimal treatment for testicular cancer (Howard et al, 1995).
Our findings are in line with these studies and suggest that the
problem is primarily one of distance from cancer centres. If these
findings are confirmed by further research, and equity of access to
cancer treatment remains a priority (EAGC, 1995), then changes
may be needed to ease and streamline referral and treatment for
more remote patients.
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